188 related articles for article (PubMed ID: 24199816)
1. Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score.
Tortora F; Cirillo M; Ferrara M; Belfiore MP; Carella C; Caranci F; Cirillo S
Neuroradiol J; 2013 Oct; 26(5):555-64. PubMed ID: 24199816
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of short-time inversion recovery sequence in Graves' Ophthalmopathy before and after prednisone treatment.
Tortora F; Prudente M; Cirillo M; Elefante A; Belfiore MP; Romano F; Cappabianca S; Carella C; Cirillo S
Neuroradiology; 2014 May; 56(5):353-61. PubMed ID: 24573324
[TBL] [Abstract][Full Text] [Related]
3. Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy--a pilot study at 1.5 T.
Kirsch EC; Kaim AH; De Oliveira MG; von Arx G
Neuroradiology; 2010 Feb; 52(2):91-7. PubMed ID: 19756565
[TBL] [Abstract][Full Text] [Related]
4. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
[TBL] [Abstract][Full Text] [Related]
5. Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy.
Tachibana S; Murakami T; Noguchi H; Noguchi Y; Nakashima A; Ohyabu Y; Noguchi S
Endocr J; 2010; 57(10):853-61. PubMed ID: 20733265
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity.
Jiang H; Wang Z; Xian J; Li J; Chen Q; Ai L
Acta Radiol; 2012 Feb; 53(1):87-94. PubMed ID: 22184678
[TBL] [Abstract][Full Text] [Related]
7. [Management of Graves' ophthalmopathy by using orbital magnetic resonance imaging].
Hiromatsu Y; Eguchi H; Tani J
Nihon Rinsho; 2012 Nov; 70(11):1932-7. PubMed ID: 23214064
[TBL] [Abstract][Full Text] [Related]
8. TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.
Mukasa K; Yoshimura Noh J; Kouzaki A; Ohye H; Kunii Y; Watanabe N; Yoshihara A; Matsumoto M; Suzuki M; Ito K
Endocr J; 2016; 63(2):151-7. PubMed ID: 26581710
[TBL] [Abstract][Full Text] [Related]
9. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy].
Rodríguez-González N; Pérez-Rico C; López-Para Giménez R; Arévalo-Serrano J; Del Amo García B; Calzada Domingo L; Flores Ruiz L; Blanco R
Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641
[TBL] [Abstract][Full Text] [Related]
10. Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves' Ophthalmopathy.
Li Z; Luo Y; Feng X; Zhang Q; Zhong Q; Weng C; Chen Z; Shen J
J Magn Reson Imaging; 2023 Oct; 58(4):1279-1289. PubMed ID: 36780178
[TBL] [Abstract][Full Text] [Related]
11. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.
Mourits MP; Prummel MF; Wiersinga WM; Koornneef L
Clin Endocrinol (Oxf); 1997 Jul; 47(1):9-14. PubMed ID: 9302365
[TBL] [Abstract][Full Text] [Related]
12. Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease.
Mayer EJ; Fox DL; Herdman G; Hsuan J; Kabala J; Goddard P; Potts MJ; Lee RW
Eur J Radiol; 2005 Oct; 56(1):20-4. PubMed ID: 15896938
[TBL] [Abstract][Full Text] [Related]
13. Lacrimal gland herniation in Graves ophthalmopathy: a simple and useful MRI biomarker of disease activity.
Gagliardo C; Radellini S; Morreale Bubella R; Falanga G; Richiusa P; Vadalà M; Ciresi A; Midiri M; Giordano C
Eur Radiol; 2020 Apr; 30(4):2138-2141. PubMed ID: 31953667
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.
Prummel MF; Gerding MN; Zonneveld FW; Wiersinga WM
Clin Endocrinol (Oxf); 2001 Feb; 54(2):205-9. PubMed ID: 11207635
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Analysis of Inflammation in Orbital Fat of Thyroid-associated Ophthalmopathy Using MRI Signal Intensity.
Higashiyama T; Iwasa M; Ohji M
Sci Rep; 2017 Dec; 7(1):16874. PubMed ID: 29203853
[TBL] [Abstract][Full Text] [Related]
16. Improvement of the MRI and clinical features of Asian Graves' ophthalmopathy by radiation therapy with steroids.
Ma Z; Ozaki H; Ishikawa Y; Jingu K
Jpn J Radiol; 2019 Aug; 37(8):612-618. PubMed ID: 31201593
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and differential diagnosis of Graves' orbitopathy in MRI].
Daubner D; Spieth S; Engellandt K; von Kummer R
Radiologe; 2012 Jun; 52(6):550-9. PubMed ID: 22622414
[TBL] [Abstract][Full Text] [Related]
18. Clinical Features of Graves' Ophthalmopathy and Impact of Enalapril on the Course of Mild Graves' Ophthalmopathy: A Pilot Study.
Ataabadi G; Dabbaghmanesh MH; Owji N; Bakhshayeshkaram M; Montazeri-Najafabady N
Endocr Metab Immune Disord Drug Targets; 2020; 20(1):139-148. PubMed ID: 31345156
[TBL] [Abstract][Full Text] [Related]
19. The application of temperature measurement of the eyes by digital infrared thermal imaging as a prognostic factor of methylprednisolone pulse therapy for Graves' ophthalmopathy.
Shih SR; Li HY; Hsiao YL; Chang TC
Acta Ophthalmol; 2010 Aug; 88(5):e154-9. PubMed ID: 20553230
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves' ophthalmopathy: a prospective, randomized controlled trial.
He Y; Mu K; Liu R; Zhang J; Xiang N
Endocr J; 2017 Feb; 64(2):141-149. PubMed ID: 27853049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
